The US-based Australian sleep apnoea device giant has exceeded expectations with strong second quarter numbers.

Elsewhere, analysts at Morgan Stanley have an overweight rating and $136.50 price target and Goldman Sachs has a buy rating ...

Senior doctors at Mackay Base Hospital have raised concerns about whether senior medical officers are working within the ...

The 28 vulnerable boarders due to be evicted from a Sydney boarding house this weekend have been given a one month reprieve, ...

Health Minister Simeon Brown is expected to confirm the future of the Dunedin Hospital project today. The new health minister ...

There will be no captains' photoshoot or conference in Pakistan before the ICC Champions Trophy, a source in the host cricket ...

The Nikon Z50II ($909.95, body only) may seem like only a slight upgrade at a glance—after all, it looks very similar to the ...